News
-
A consortium of life sciences companies jointly commit expertise & assets to fight COVID-19 alongside the Bill & Melinda Gates Foundation
An unprecedented collaboration across government, academia, private sector, and philanthropy is taking place as a response to the coronavirus global crisis. Today, a consortium of life sciences companies announced an…
Read More » -
FDA and EMA Collaborate to Facilitate COVID-19 Vaccine Development
Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines…
Read More » -
The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF
Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer…
Read More » -
Novartis To Donate Up To 130 Million Doses Of Hydroxychloroquine To Treat Covid-19
On Friday, 20 March, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related…
Read More » -
TIF’s enriched Leaflet ”The COVID-19 Pandemic & Haemoglobin Disorders” is available today!
During these difficult and challenging times the coronavirus (COVID-19) pandemic is creating at a global level, individuals with underlying medical conditions, such as blood disorders, heart disease, chronic liver disease,…
Read More » -
A Useful Health & Nutrition Short Guide for the COVID-19 Pandemic by TIF
The coronavirus presents many uncertainties, and none of us can completely eliminate the risk of getting infected with COVID-19. Nevertheless, one thing we can do is eat as healthy as…
Read More » -
AABB’s Develops Toolkit with Information Regarding Blood Donation & the COVID-19 Outbreak
As the new coronavirus continues to spread affecting an increasing number of countries around the globe and in response to FDA’s Important Information for Blood Establishments Regarding the Novel Coronavirus…
Read More » -
FT-4202 Granted FDA Fast Track, Rare Pediatric Disease Designations for SCD
FT-4202, a potential disease-modifying oral treatment for sickle cell disease being developed by Forma Therapeutics, has been given fast track and rare pediatric disease designations by the U.S. Food and Drug Administration (FDA). A fast track status…
Read More » -
Rare Disease Day 2020: Abundance of events & vast participation are expected in this year’s RDD
Observed every year on the last day of February and in the 29th of February in 2020, Rare Disease Day seeks to raise awareness among the general public, as well…
Read More » -
